• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validity of ligand efficiency metrics.配体效率指标的有效性。
ACS Med Chem Lett. 2014 May 9;5(6):616-8. doi: 10.1021/ml500146d. eCollection 2014 Jun 12.
2
Improving the plausibility of success with inefficient metrics.用低效的指标提高成功的可信度。
ACS Med Chem Lett. 2013 Nov 21;5(1):2-5. doi: 10.1021/ml4004638. eCollection 2014 Jan 9.
3
An Innovation 10 Years in the Making: The Stories in the Pages of .十年磨一剑的创新:书页中的故事
ACS Med Chem Lett. 2022 Feb 3;13(4):540-545. doi: 10.1021/acsmedchemlett.1c00623. eCollection 2022 Apr 14.
4
Practical application of ligand efficiency metrics in lead optimisation.配体效率指标在先导优化中的实际应用。
Bioorg Med Chem. 2018 Jul 15;26(11):3006-3015. doi: 10.1016/j.bmc.2018.04.004. Epub 2018 Apr 5.
5
Beware of ligand efficiency (LE): understanding LE data in modeling structure-activity and structure-economy relationships.谨防配体效率(LE):理解结构-活性和结构-经济性关系建模中的LE数据。
J Cheminform. 2017 Sep 11;9(1):49. doi: 10.1186/s13321-017-0236-9.
6
Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.通过设计改进候选药物:关注物理化学性质,以改善化合物处置和安全性。
Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26.
7
The thermodynamic basis for the use of lipophilic efficiency (LipE) in enthalpic optimizations.亲脂效率(LipE)在焓优化中应用的热力学基础。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5992-6000. doi: 10.1016/j.bmcl.2013.08.030. Epub 2013 Aug 14.
8
Ligand efficiency-based support vector regression models for predicting bioactivities of ligands to drug target proteins.基于配体效率的支持向量回归模型预测配体对药物靶标蛋白的生物活性。
J Chem Inf Model. 2014 Oct 27;54(10):2751-63. doi: 10.1021/ci5003262. Epub 2014 Sep 22.
9
Formation of activity cliffs is accompanied by systematic increases in ligand efficiency from lowly to highly potent compounds.活性峰的形成伴随着配体效率从低效到高效化合物的系统增加。
AAPS J. 2014 Mar;16(2):335-41. doi: 10.1208/s12248-014-9567-x. Epub 2014 Jan 30.
10
Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space.改进药物设计:效率指标近期应用、替换有问题元素的策略以及非传统药物领域化合物的最新进展
Chem Res Toxicol. 2016 Apr 18;29(4):564-616. doi: 10.1021/acs.chemrestox.6b00043. Epub 2016 Mar 14.

引用本文的文献

1
Development of Fragment-Based Inhibitors of the Bacterial Deacetylase LpxC with Low Nanomolar Activity.基于片段的细菌去乙酰化酶 LpxC 抑制剂的开发,具有低纳摩尔活性。
J Med Chem. 2024 Oct 10;67(19):17363-17391. doi: 10.1021/acs.jmedchem.4c01262. Epub 2024 Sep 20.
2
Inhibition of Monkeypox Virus DNA Polymerase Using Phytochemicals: Computational Studies of Drug-Likeness, Molecular Docking, Molecular Dynamics Simulation and Density Functional Theory.使用植物化学物质抑制猴痘病毒DNA聚合酶:药物相似性、分子对接、分子动力学模拟和密度泛函理论的计算研究
Indian J Microbiol. 2024 Sep;64(3):1057-1074. doi: 10.1007/s12088-024-01244-3. Epub 2024 Mar 28.
3
Network Pharmacology, Molecular Docking and -based Analysis on the Effects of the MBZM-N-IBT for Arthritis.基于网络药理学、分子对接的MBZM-N-IBT对关节炎作用的分析
Curr Comput Aided Drug Des. 2025;21(2):194-210. doi: 10.2174/0115734099307360240731052835.
4
ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights.内质网氨基肽酶(ERAP)抑制剂在自身免疫和免疫肿瘤学中的作用:药物化学研究进展。
J Med Chem. 2024 Jul 25;67(14):11597-11621. doi: 10.1021/acs.jmedchem.4c00840. Epub 2024 Jul 16.
5
Unveiling the Potential of -Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery.揭示 - 贝壳杉烷二萜类化合物的潜力:用于药物发现的多面天然产物。
Pharmaceuticals (Basel). 2024 Apr 16;17(4):510. doi: 10.3390/ph17040510.
6
Identification of small-molecule binding sites of a ubiquitin-conjugating enzyme-UBE2T through fragment-based screening.通过基于片段的筛选鉴定泛素连接酶 UBE2T 的小分子结合位点。
Protein Sci. 2024 Mar;33(3):e4904. doi: 10.1002/pro.4904.
7
The Anti-Virulence Activities of the Antihypertensive Drug Propranolol in Light of Its Anti-Quorum Sensing Effects against and .基于抗群体感应作用的降压药普萘洛尔的抗毒力活性:针对[具体菌株1]和[具体菌株2]
Biomedicines. 2023 Nov 28;11(12):3161. doi: 10.3390/biomedicines11123161.
8
2-Alkyl-Substituted-4-Amino-Thieno[2,3-]Pyrimidines: Anti-Proliferative Properties to In Vitro Breast Cancer Models.2- 烷基取代-4-氨基噻吩并[2,3-d]嘧啶类化合物:体外乳腺癌模型的抗增殖活性。
Molecules. 2023 Aug 30;28(17):6347. doi: 10.3390/molecules28176347.
9
Deciphering Molecular Aspects of Potential -Glucosidase Inhibitors within : A Computational Odyssey of Molecular Docking-Coupled Dynamics Simulations and Pharmacokinetic Profiling.解析潜在α-葡萄糖苷酶抑制剂的分子层面:分子对接耦合动力学模拟与药代动力学分析的计算历程
Metabolites. 2023 Aug 12;13(8):942. doi: 10.3390/metabo13080942.
10
Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-]pyridine-6-carboxamide Scaffold Enabled the Discovery of New Ligands with High Affinity and Selectivity for the Cannabinoid Type 2 Receptor.系统修饰 7-羟基-5-氧代吡唑并[4,3-]吡啶-6-甲酰胺支架的取代模式,发现了对大麻素 2 型受体具有高亲和力和选择性的新型配体。
Molecules. 2023 Jun 24;28(13):4958. doi: 10.3390/molecules28134958.

本文引用的文献

1
Improving the plausibility of success with inefficient metrics.用低效的指标提高成功的可信度。
ACS Med Chem Lett. 2013 Nov 21;5(1):2-5. doi: 10.1021/ml4004638. eCollection 2014 Jan 9.
2
The role of ligand efficiency metrics in drug discovery.配体效率指标在药物发现中的作用。
Nat Rev Drug Discov. 2014 Feb;13(2):105-21. doi: 10.1038/nrd4163.
3
Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters.在分子优化中设定预期:常用综合参数的优缺点。
Bioorg Med Chem Lett. 2013 Nov 1;23(21):5980-91. doi: 10.1016/j.bmcl.2013.08.029. Epub 2013 Aug 13.
4
Assessing the lipophilicity of fragments and early hits.评估片段和早期命中物的亲脂性。
J Comput Aided Mol Des. 2011 Jul;25(7):663-7. doi: 10.1007/s10822-011-9435-z. Epub 2011 May 26.
5
Simple size-independent measure of ligand efficiency.配体效率的简单的与大小无关的衡量指标。
J Chem Inf Model. 2009 Jun;49(6):1617-22. doi: 10.1021/ci900094m.
6
The influence of lead discovery strategies on the properties of drug candidates.先导化合物发现策略对候选药物性质的影响。
Nat Rev Drug Discov. 2009 Mar;8(3):203-12. doi: 10.1038/nrd2796.
7
Ligand binding efficiency: trends, physical basis, and implications.配体结合效率:趋势、物理基础及影响
J Med Chem. 2008 Apr 24;51(8):2432-8. doi: 10.1021/jm701255b. Epub 2008 Apr 2.
8
The influence of drug-like concepts on decision-making in medicinal chemistry.类药概念对药物化学决策的影响。
Nat Rev Drug Discov. 2007 Nov;6(11):881-90. doi: 10.1038/nrd2445.
9
Ligand efficiency: a useful metric for lead selection.配体效率:先导化合物筛选的有用指标。
Drug Discov Today. 2004 May 15;9(10):430-1. doi: 10.1016/S1359-6446(04)03069-7.
10
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.药物研发环境中估算溶解度和渗透性的实验与计算方法。
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26. doi: 10.1016/s0169-409x(00)00129-0.

配体效率指标的有效性。

Validity of ligand efficiency metrics.

作者信息

Murray Christopher W, Erlanson Daniel A, Hopkins Andrew L, Keserü György M, Leeson Paul D, Rees David C, Reynolds Charles H, Richmond Nicola J

机构信息

Astex Pharmaceuticals , 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA, U.K.

Carmot Therapeutics, Inc. , 409 Illinois Street, San Francisco, California 94158, United States.

出版信息

ACS Med Chem Lett. 2014 May 9;5(6):616-8. doi: 10.1021/ml500146d. eCollection 2014 Jun 12.

DOI:10.1021/ml500146d
PMID:24944729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4060940/
Abstract

A recent viewpoint article (Improving the plausibility of success with inefficient metrics. ACS Med. Chem. Lett. 2014, 5, 2-5) argued that the standard definition of ligand efficiency (LE) is mathematically invalid. In this viewpoint, we address this criticism and show categorically that the definition of LE is mathematically valid. LE and other metrics such as lipophilic ligand efficiency (LLE) can be useful during the multiparameter optimization challenge faced by medicinal chemists.

摘要

最近的一篇观点文章(《用低效指标提高成功的可信度。美国化学会药物化学通讯》,2014年,第5卷,第2 - 5页)认为配体效率(LE)的标准定义在数学上是无效的。在这篇观点文章中,我们回应了这一批评,并明确表明LE的定义在数学上是有效的。在药物化学家面临的多参数优化挑战中,LE以及其他指标如亲脂性配体效率(LLE)可能会有所帮助。